Global PROteolysis Targeting Chimera (PROTAC) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18692146 | Publishing Date : 02-Jul-2021 | No. of pages : 118
Detailed TOC of Global PROteolysis Targeting Chimera (PROTAC) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 PROteolysis Targeting Chimera (PROTAC) Market Overview1.1 PROteolysis Targeting Chimera (PROTAC) Product Overview
1.2 PROteolysis Targeting Chimera (PROTAC) Market Segment by Type
1.2.1 ARV-110
1.2.2 ARV-471
1.2.3 KYM-001
1.2.4 Others
1.3 Global PROteolysis Targeting Chimera (PROTAC) Market Size by Type
1.3.1 Global PROteolysis Targeting Chimera (PROTAC) Market Size Overview by Type (2016-2027)
1.3.2 Global PROteolysis Targeting Chimera (PROTAC) Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global PROteolysis Targeting Chimera (PROTAC) Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global PROteolysis Targeting Chimera (PROTAC) Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Type (2016-2021)
1.4.2 Europe PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Type (2016-2021)
1.4.4 Latin America PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Type (2016-2021)
2 Global PROteolysis Targeting Chimera (PROTAC) Market Competition by Company
2.1 Global Top Players by PROteolysis Targeting Chimera (PROTAC) Sales (2016-2021)
2.2 Global Top Players by PROteolysis Targeting Chimera (PROTAC) Revenue (2016-2021)
2.3 Global Top Players PROteolysis Targeting Chimera (PROTAC) Price (2016-2021)
2.4 Global Top Manufacturers PROteolysis Targeting Chimera (PROTAC) Manufacturing Base Distribution, Sales Area, Product Type
2.5 PROteolysis Targeting Chimera (PROTAC) Market Competitive Situation and Trends
2.5.1 PROteolysis Targeting Chimera (PROTAC) Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PROteolysis Targeting Chimera (PROTAC) as of 2020)
2.7 Date of Key Manufacturers Enter into PROteolysis Targeting Chimera (PROTAC) Market
2.8 Key Manufacturers PROteolysis Targeting Chimera (PROTAC) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PROteolysis Targeting Chimera (PROTAC) Status and Outlook by Region
3.1 Global PROteolysis Targeting Chimera (PROTAC) Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global PROteolysis Targeting Chimera (PROTAC) Historic Market Size by Region
3.2.1 Global PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Region (2016-2021)
3.2.2 Global PROteolysis Targeting Chimera (PROTAC) Sales in Value by Region (2016-2021)
3.2.3 Global PROteolysis Targeting Chimera (PROTAC) Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Region
3.3.1 Global PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Region (2022-2027)
3.3.2 Global PROteolysis Targeting Chimera (PROTAC) Sales in Value by Region (2022-2027)
3.3.3 Global PROteolysis Targeting Chimera (PROTAC) Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global PROteolysis Targeting Chimera (PROTAC) by Application
4.1 PROteolysis Targeting Chimera (PROTAC) Market Segment by Application
4.1.1 Oncology
4.1.2 Others
4.2 Global PROteolysis Targeting Chimera (PROTAC) Market Size by Application
4.2.1 Global PROteolysis Targeting Chimera (PROTAC) Market Size Overview by Application (2016-2027)
4.2.2 Global PROteolysis Targeting Chimera (PROTAC) Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global PROteolysis Targeting Chimera (PROTAC) Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global PROteolysis Targeting Chimera (PROTAC) Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global PROteolysis Targeting Chimera (PROTAC) Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Application (2016-2021)
4.3.2 Europe PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Application (2016-2021)
4.3.4 Latin America PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Breakdown by Application (2016-2021)
5 North America PROteolysis Targeting Chimera (PROTAC) by Country
5.1 North America PROteolysis Targeting Chimera (PROTAC) Historic Market Size by Country
5.1.1 North America PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2016-2021)
5.1.2 North America PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2016-2021)
5.2 North America PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Country
5.2.1 North America PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2022-2027)
5.2.2 North America PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2022-2027)
6 Europe PROteolysis Targeting Chimera (PROTAC) by Country
6.1 Europe PROteolysis Targeting Chimera (PROTAC) Historic Market Size by Country
6.1.1 Europe PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2016-2021)
6.1.2 Europe PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2016-2021)
6.2 Europe PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Country
6.2.1 Europe PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2022-2027)
6.2.2 Europe PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2022-2027)
7 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) by Region
7.1 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Historic Market Size by Region
7.1.1 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales in Value by Region (2016-2021)
7.2 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Region
7.2.1 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales in Value by Region (2022-2027)
8 Latin America PROteolysis Targeting Chimera (PROTAC) by Country
8.1 Latin America PROteolysis Targeting Chimera (PROTAC) Historic Market Size by Country
8.1.1 Latin America PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2016-2021)
8.1.2 Latin America PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2016-2021)
8.2 Latin America PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Country
8.2.1 Latin America PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2022-2027)
8.2.2 Latin America PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2022-2027)
9 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) by Country
9.1 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Historic Market Size by Country
9.1.1 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2016-2021)
9.2 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Forecasted Market Size by Country
9.2.1 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in PROteolysis Targeting Chimera (PROTAC) Business
10.1 Arvinas
10.1.1 Arvinas Corporation Information
10.1.2 Arvinas Introduction and Business Overview
10.1.3 Arvinas PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Arvinas PROteolysis Targeting Chimera (PROTAC) Products Offered
10.1.5 Arvinas Recent Development
10.2 Kymera
10.2.1 Kymera Corporation Information
10.2.2 Kymera Introduction and Business Overview
10.2.3 Kymera PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Arvinas PROteolysis Targeting Chimera (PROTAC) Products Offered
10.2.5 Kymera Recent Development
10.3 C4 therapeutics
10.3.1 C4 therapeutics Corporation Information
10.3.2 C4 therapeutics Introduction and Business Overview
10.3.3 C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.3.4 C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Products Offered
10.3.5 C4 therapeutics Recent Development
10.4 Captor therapeutics
10.4.1 Captor therapeutics Corporation Information
10.4.2 Captor therapeutics Introduction and Business Overview
10.4.3 Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Products Offered
10.4.5 Captor therapeutics Recent Development
10.5 Vividion
10.5.1 Vividion Corporation Information
10.5.2 Vividion Introduction and Business Overview
10.5.3 Vividion PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Vividion PROteolysis Targeting Chimera (PROTAC) Products Offered
10.5.5 Vividion Recent Development
10.6 Cullgen
10.6.1 Cullgen Corporation Information
10.6.2 Cullgen Introduction and Business Overview
10.6.3 Cullgen PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Cullgen PROteolysis Targeting Chimera (PROTAC) Products Offered
10.6.5 Cullgen Recent Development
10.7 Pfizer
10.7.1 Pfizer Corporation Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Pfizer PROteolysis Targeting Chimera (PROTAC) Products Offered
10.7.5 Pfizer Recent Development
10.8 Merck
10.8.1 Merck Corporation Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Merck PROteolysis Targeting Chimera (PROTAC) Products Offered
10.8.5 Merck Recent Development
10.9 Genentech
10.9.1 Genentech Corporation Information
10.9.2 Genentech Introduction and Business Overview
10.9.3 Genentech PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Genentech PROteolysis Targeting Chimera (PROTAC) Products Offered
10.9.5 Genentech Recent Development
10.10 AstraZeneca
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 PROteolysis Targeting Chimera (PROTAC) Product Category, Application and Specification
10.10.3 AstraZeneca PROteolysis Targeting Chimera (PROTAC) Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 AstraZeneca Recent Development
10.11 Amgen
10.11.1 Amgen Corporation Information
10.11.2 Amgen Introduction and Business Overview
10.11.3 Amgen PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Amgen PROteolysis Targeting Chimera (PROTAC) Products Offered
10.11.5 Amgen Recent Development
10.12 Bayer
10.12.1 Bayer Corporation Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer PROteolysis Targeting Chimera (PROTAC) Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Bayer PROteolysis Targeting Chimera (PROTAC) Products Offered
10.12.5 Bayer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PROteolysis Targeting Chimera (PROTAC) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PROteolysis Targeting Chimera (PROTAC) Industrial Chain Analysis
11.4 PROteolysis Targeting Chimera (PROTAC) Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PROteolysis Targeting Chimera (PROTAC) Distributors
12.3 PROteolysis Targeting Chimera (PROTAC) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global PROteolysis Targeting Chimera (PROTAC) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of ARV-110
Table 2. Major Company of ARV-471
Table 3. Major Company of KYM-001
Table 4. Major Company of Others
Table 5. Global PROteolysis Targeting Chimera (PROTAC) Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (K Units)
Table 7. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type (2016-2021)
Table 8. Global PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (US& Million)
Table 9. Global PROteolysis Targeting Chimera (PROTAC) Market Share in Value by Type (2016-2021)
Table 10. Global PROteolysis Targeting Chimera (PROTAC) Price by Type (2016-2021) & (US$/Unit)
Table 11. Global PROteolysis Targeting Chimera (PROTAC) Sales by Type (2022-2027) & (K Units)
Table 12. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type (2022-2027)
Table 13. Global PROteolysis Targeting Chimera (PROTAC) Sales by Type (2022-2027) & (US$ Million)
Table 14. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type (2022-2027)
Table 15. Global PROteolysis Targeting Chimera (PROTAC) Price by Type (2022-2027) & (US$/Unit)
Table 16. North America PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (K Units)
Table 17. North America PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (US$ Million)
Table 18. Europe PROteolysis Targeting Chimera (PROTAC) Sales (K Units) by Type (2016-2021)
Table 19. Europe PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (US$ Million)
Table 20. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales (K Units) by Type (2016-2021)
Table 21. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (US$ Million)
Table 22. Latin America PROteolysis Targeting Chimera (PROTAC) Sales (K Units) by Type (2016-2021)
Table 23. Latin America PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (US$ Million)
Table 24. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales (K Units) by Type (2016-2021)
Table 25. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2021) & (US$ Million)
Table 26. Global PROteolysis Targeting Chimera (PROTAC) Sales by Company (2016-2021) & (K Units)
Table 27. Global PROteolysis Targeting Chimera (PROTAC) Sales Share by Company (2016-2021)
Table 28. Global PROteolysis Targeting Chimera (PROTAC) Revenue by Company (2016-2021) & (US$ Million)
Table 29. Global PROteolysis Targeting Chimera (PROTAC) Revenue Share by Company (2016-2021)
Table 30. Global Market PROteolysis Targeting Chimera (PROTAC) Price by Company (2016-2021) & (US$/Unit)
Table 31. Global PROteolysis Targeting Chimera (PROTAC) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global PROteolysis Targeting Chimera (PROTAC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PROteolysis Targeting Chimera (PROTAC) as of 2020
Table 34. Date of Key Manufacturers Enter into PROteolysis Targeting Chimera (PROTAC) Market
Table 35. Key Manufacturers PROteolysis Targeting Chimera (PROTAC) Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global PROteolysis Targeting Chimera (PROTAC) Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 38. Global PROteolysis Targeting Chimera (PROTAC) Sales by Region (2016-2021) & (K Units)
Table 39. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Region (2016-2021)
Table 40. Global PROteolysis Targeting Chimera (PROTAC) Sales by Region (2016-2021) & (US$ Million)
Table 41. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Region (2016-2021)
Table 42. Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 43. Global PROteolysis Targeting Chimera (PROTAC) Sales by Region (2022-2027) & (K Units)
Table 44. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Region (2022-2027)
Table 45. Global PROteolysis Targeting Chimera (PROTAC) Sales by Region (2022-2027) & (US$ Million)
Table 46. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Region (2022-2027)
Table 47. Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027)
Table 48. Global PROteolysis Targeting Chimera (PROTAC) Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 49. Global PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) & (K Units)
Table 50. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Application (2016-2021)
Table 51. Global PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) & (US$ Million)
Table 52. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application (2016-2021)
Table 53. Global PROteolysis Targeting Chimera (PROTAC) Price by Application (2016-2021) & (US$/Unit)
Table 54. Global PROteolysis Targeting Chimera (PROTAC) Sales by Application (2022-2027) & (K Units)
Table 55. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Application (2022-2027)
Table 56. Global PROteolysis Targeting Chimera (PROTAC) Sales by Application (2022-2027) & (US$ Million)
Table 57. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application (2022-2027)
Table 58. Global PROteolysis Targeting Chimera (PROTAC) Price by Application (2022-2027) & (US$/Unit)
Table 59. North America PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) (K Units)
Table 60. North America PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) & (US$ Million)
Table 61. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application in 2020
Table 62. Europe PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) (K Units)
Table 63. Europe PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) & (US$ Million)
Table 64. Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application in 2020
Table 65. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) (K Units)
Table 66. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) & (US$ Million)
Table 67. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application in 2020
Table 68. Latin America PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) (K Units)
Table 69. Latin America PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) & (US$ Million)
Table 70. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application in 2020
Table 71. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) (K Units)
Table 72. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2021) & (US$ Million)
Table 73. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application in 2020
Table 74. North America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (K Units)
Table 75. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2016-2021)
Table 76. North America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (US$ Million)
Table 77. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2016-2021)
Table 78. North America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (K Units)
Table 79. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2022-2027)
Table 80. North America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (US$ Million)
Table 81. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2022-2027)
Table 82. Europe PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (K Units)
Table 83. Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2016-2021)
Table 84. Europe PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (US$ Million)
Table 85. Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2016-2021)
Table 86. Europe PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (K Units)
Table 87. Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2022-2027)
Table 88. Europe PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (US$ Million)
Table 89. Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2022-2027)
Table 90. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales by Region (2016-2021) & (K Units)
Table 91. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Region (2016-2021)
Table 92. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales by Region (2016-2021) & (US$ Million)
Table 93. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Region (2016-2021)
Table 94. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales by Region (2022-2027) & (K Units)
Table 95. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Region (2022-2027)
Table 96. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales by Region (2022-2027) & (US$ Million)
Table 97. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Region (2022-2027)
Table 98. Latin America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (K Units)
Table 99. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2016-2021)
Table 100. Latin America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (US$ Million)
Table 101. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2016-2021)
Table 102. Latin America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (K Units)
Table 103. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2022-2027)
Table 104. Latin America PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (US$ Million)
Table 105. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2022-2027)
Table 106. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (K Units)
Table 107. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2016-2021)
Table 108. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales by Country (2016-2021) & (US$ Million)
Table 109. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2016-2021)
Table 110. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (K Units)
Table 111. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Country (2022-2027)
Table 112. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales by Country (2022-2027) & (US$ Million)
Table 113. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Country (2022-2027)
Table 114. Arvinas Corporation Information
Table 115. Arvinas Introduction and Business Overview
Table 116. Arvinas PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Arvinas PROteolysis Targeting Chimera (PROTAC) Product
Table 118. Arvinas Recent Development
Table 119. Kymera Corporation Information
Table 120. Kymera Introduction and Business Overview
Table 121. Kymera PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Kymera PROteolysis Targeting Chimera (PROTAC) Product
Table 123. Kymera Recent Development
Table 124. C4 therapeutics Corporation Information
Table 125. C4 therapeutics Introduction and Business Overview
Table 126. C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Product
Table 128. C4 therapeutics Recent Development
Table 129. Captor therapeutics Corporation Information
Table 130. Captor therapeutics Introduction and Business Overview
Table 131. Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Product
Table 133. Captor therapeutics Recent Development
Table 134. Vividion Corporation Information
Table 135. Vividion Introduction and Business Overview
Table 136. Vividion PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. Vividion PROteolysis Targeting Chimera (PROTAC) Product
Table 138. Vividion Recent Development
Table 139. Cullgen Corporation Information
Table 140. Cullgen Introduction and Business Overview
Table 141. Cullgen PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 142. Cullgen PROteolysis Targeting Chimera (PROTAC) Product
Table 143. Cullgen Recent Development
Table 144. Pfizer Corporation Information
Table 145. Pfizer Introduction and Business Overview
Table 146. Pfizer PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Pfizer PROteolysis Targeting Chimera (PROTAC) Product
Table 148. Pfizer Recent Development
Table 149. Merck Corporation Information
Table 150. Merck Introduction and Business Overview
Table 151. Merck PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Merck PROteolysis Targeting Chimera (PROTAC) Product
Table 153. Merck Recent Development
Table 154. Genentech Corporation Information
Table 155. Genentech Introduction and Business Overview
Table 156. Genentech PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 157. Genentech PROteolysis Targeting Chimera (PROTAC) Product
Table 158. Genentech Recent Development
Table 159. AstraZeneca Corporation Information
Table 160. AstraZeneca Introduction and Business Overview
Table 161. AstraZeneca PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 162. AstraZeneca PROteolysis Targeting Chimera (PROTAC) Product
Table 163. AstraZeneca Recent Development
Table 164. Amgen Corporation Information
Table 165. Amgen Introduction and Business Overview
Table 166. Amgen PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 167. Amgen PROteolysis Targeting Chimera (PROTAC) Product
Table 168. Amgen Recent Development
Table 169. Bayer Corporation Information
Table 170. Bayer Introduction and Business Overview
Table 171. Bayer PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 172. Bayer PROteolysis Targeting Chimera (PROTAC) Product
Table 173. Bayer Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. PROteolysis Targeting Chimera (PROTAC) Market Trends
Table 177. PROteolysis Targeting Chimera (PROTAC) Market Drivers
Table 178. PROteolysis Targeting Chimera (PROTAC) Market Challenges
Table 179. PROteolysis Targeting Chimera (PROTAC) Market Restraints
Table 180. PROteolysis Targeting Chimera (PROTAC) Distributors List
Table 181. PROteolysis Targeting Chimera (PROTAC) Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. PROteolysis Targeting Chimera (PROTAC) Product Picture
Figure 2. Global PROteolysis Targeting Chimera (PROTAC) Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global PROteolysis Targeting Chimera (PROTAC) Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global PROteolysis Targeting Chimera (PROTAC) Sales Status and Outlook (2016-2027) & (K Units)
Figure 5. Product Picture of ARV-110
Figure 6. Global ARV-110 Sales YoY Growth (2016-2021) & (K Units)
Figure 7. Product Picture of ARV-471
Figure 8. Global ARV-471 Sales YoY Growth (2016-2021) & (K Units)
Figure 9. Product Picture of KYM-001
Figure 10. Global KYM-001 Sales YoY Growth (2016-2021) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2016-2021) & (K Units)
Figure 13. Global PROteolysis Targeting Chimera (PROTAC) Sales by Type (2016-2027) & (US$ Million)
Figure 14. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type (2016-2021)
Figure 15. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type (2016-2021)
Figure 16. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type (2022-2027)
Figure 17. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type (2022-2027)
Figure 18. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type in 2020
Figure 19. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type in 2020
Figure 20. Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type in 2020
Figure 21. Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type in 2020
Figure 22. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type in 2020
Figure 23. Asia-Pacific PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type in 2020
Figure 24. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type in 2020
Figure 25. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type in 2020
Figure 26. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Type in 2020
Figure 27. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Type in 2020
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by PROteolysis Targeting Chimera (PROTAC) Sales in 2020
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by PROteolysis Targeting Chimera (PROTAC) Revenue in 2020
Figure 30. PROteolysis Targeting Chimera (PROTAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Product Picture of Oncology
Figure 32. Global Oncology Sales YoY Growth (2016-2027) & (K Units)
Figure 33. Product Picture of Others
Figure 34. Global Others Sales YoY Growth (2016-2027) & (K Units)
Figure 35. Global PROteolysis Targeting Chimera (PROTAC) Sales by Application (2016-2027) & (US$ Million)
Figure 36. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Application (2016-2021)
Figure 37. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application (2016-2021)
Figure 38. Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Application (2022-2027)
Figure 39. North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Volume by Application in 2020
Figure 40. Latin America PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application in 2020
Figure 41. Middle East and Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share in Value by Application in 2020
Figure 42. Key Raw Materials Price
Figure 43. PROteolysis Targeting Chimera (PROTAC) Manufacturing Cost Structure
Figure 44. PROteolysis Targeting Chimera (PROTAC) Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Keyplayers in Global PROteolysis Targeting Chimera (PROTAC) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
ArvinasKymera
C4 therapeutics
Captor therapeutics
Vividion
Cullgen
Pfizer
Merck
Genentech
AstraZeneca
Amgen
Bayer